ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

The emergence of acquired resistance limits the long-term efficacy of EGFR tyrosine kinase inhibitors (EGFR TKIs). Thus, development of effective strategies to overcome resistance to EGFR TKI is urgently needed. Multiple mechanisms to reactivate ERK signaling have been successfully demonstrated in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Bo Mi, Heo, Jae Yeong, Kim, Jinchul, sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993753/
https://www.ncbi.nlm.nih.gov/pubmed/34973117
http://dx.doi.org/10.1007/s10637-021-01121-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993753/
https://www.ncbi.nlm.nih.gov/pubmed/34973117
http://dx.doi.org/10.1007/s10637-021-01121-6

Ejemplares similares